Volume 99, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



is an intestinal protozoan, usually considered nonpathogenic. However, in the last years, there has been an attempt to clarify its possible pathogenic role. We aim to evaluate the clinical and epidemiological characteristics of –infected patients. Adults with detection in feces who attended the Vall d’Hebron University Hospital (Barcelona, Spain) were evaluated retrospectively from April 2009 to March 2014. We classified the patients in asymptomatic, symptomatic without other causes except infection of , and symptomatic with another cause. Among symptomatic patients, treatment response was evaluated. One hundred eight patients were included. Sixty-three percent of the patients were immigrants, 29.6% were autochthonous, and 7.4% were travelers. Forty-nine (45.3%) patients presented symptoms, and eosinophilia was observed in 26 (24.1%) patients. Overall, 59 (54.7%) patients were asymptomatic, 15 (13.8%) presented symptoms which were attributable to other causes, and 34 (31.5%) patients presented symptoms with no other causes. In this last group, 29 patients received specific treatment and 65.5% of them presented a complete resolution of the symptoms. The group of symptomatic patients with no other cause had more proportion of women, more proportion of autochthonous people, and were older compared with the group of asymptomatic patients. infection should be considered as pathogenic when other causes are ruled out.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Cacciò SM, 2016. Multilocus sequence typing of Dientamoeba fragilis identified a major clone with widespread geographical distribution. Int J Parasitol 46: 793798. [Google Scholar]
  2. Norberg A, Nord CE, Evengard B, , 2003. Dientamoeba fragilis a protozoan infection which may cause severe bowel distress. Clin Microbiol Infect 9: 6568. [Google Scholar]
  3. Stark D, García LS, Barratt JL, Phillips O, Roberts T, Marriott D, Harkness J, Ellis JT, , 2014. Description of Dientamoeba fragilis cyst and precystic forms from human samples. J Clin Microbiol 52: 26802683. [Google Scholar]
  4. Windsor JJ, Johnson EH, , 1998. Dientamoeba fragilis: the unflagelated flagellate. Br J Biomed Sci 55: 172175. [Google Scholar]
  5. Johnson EH, Windsor JJ, Clark C, , 2004. Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis. Clin Microbiol Rev 17: 553570. [Google Scholar]
  6. Stark D, Barratt J, Chan D, Ellis JT, , 2016. Dientamoeba fragilis, the neglected trichomonad of the human bowel. Clin Microbiol Rev 29: 553580. [Google Scholar]
  7. Ockert G, Schmidt T, , 1976. Evidence of Dientamoeba fragilis in Enterobius eggs using isoelectric point determination. J Hyg Epidemiol Microbiol Immunol 20: 7681. [Google Scholar]
  8. Boga JA, Rojo S, Fernández J, Rodríguez M, Iglesias C, Martínez-Camblor P, Vázquez F, Rodríguez-Guardado A, , 2016. Is the treatment of Enterobius vermicularis co-infection necessary to eradicate Dientamoeba fragilis infection? Int J Infect Dis 49: 5961. [Google Scholar]
  9. Stark D, Barratt J, Roberts T, Marriott D, Harkness J, Ellis J, , 2010. A review of the clinical presentation of dientamoebiasis. Am J Trop Med Hyg 82: 614619. [Google Scholar]
  10. Stark D, Beebe N, Marriott D, Ellis J, Harkness J, , 2005. Prospective study of the prevalence, genotyping, and clinical relevance of Dientamoeba fragilis infections in an Australian population. J Clin Microbiol 43: 27182723. [Google Scholar]
  11. Munasinghe VS, Vella GN, Ellis JT, Windsor PA, Stark D, , 2013. Cyst formation and faecal–oral transmission of Dientamoeba fragilis–the missing link in the life cycle of an emerging pathogen. Int J Parasitol 43: 879883. [Google Scholar]
  12. Holtman GA, Kranenberg JJ, Blanker MH, Ott A, Lisman-van Leeuwen Y, Berger MY, , 2017. Dientamoeba fragilis colonization is not associated with gastrointestinal symptoms in children at primary care level. Fam Pract 34: 2529. [Google Scholar]
  13. Nagata N, Marriott D, Harkness J, Ellis JT, Stark D, , 2012. Current treatment options for Dientamoeba fragilis infections. Int J Parasitol Drugs Drug Resist 2: 204215. [Google Scholar]
  14. Garcia LS, , 2016. Dientamoeba fragilis, one of the neglected intestinal protozoa. J Clin Microbiol 54: 22432250. [Google Scholar]
  15. Engsbro AL, Stensvold CR, Nielsen HV, Bytzer P, , 2012. Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome. Am J Trop Med Hyg 87: 10461052. [Google Scholar]

Data & Media loading...

  • Received : 23 May 2018
  • Accepted : 05 Aug 2018
  • Published online : 17 Sep 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error